[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eton Pharmaceutcials Inc 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010 USA

www.etonpharma.com Employees: 44 P: 847-787-7361

Sector:

Medical

Description:

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Key Statistics

Overview:

Market Capitalization, $K 977,894
Enterprise Value, $K 982,514
Shares Outstanding, K 27,392
Float, K 22,875
% Float 83.51%
Short Interest, K 1,261
Short Float 4.60%
Days to Cover 2.80
Short Volume Ratio 0.30
% of Insider Shareholders 16.49%
% of Institutional Shareholders 27.86%

Financials:

Annual Sales, $ 79,950 K
Annual Net Income, $ -4,600 K
Last Quarter Sales, $ 24,270 K
Last Quarter Net Income, $ 1,550 K
EBIT, $ 2,030 K
EBITDA, $ 6,770 K

Growth:

1-Year Return 155.73%
3-Year Return 922.92%
5-Year Return 494.01%
5-Year Revenue Growth 199,775.00%
5-Year Earnings Growth 87.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 05/14/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -28.57%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ETON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 46.43
Price/Earnings to Growth N/A
Return-on-Equity % -5.68%
Return-on-Assets % -1.49%
Profit Margin % -5.75%
Debt/Equity 1.00
Price/Sales 11.93
Price/Cash Flow 6,717.86
Price/Book 31.12
Book Value/Share 1.12
Interest Coverage -0.87
60-Month Beta 0.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.